555 related articles for article (PubMed ID: 32486261)
41. P2Y12 ADP receptor-dependent tyrosine phosphorylation of proteins of 27 and 31 kDa in thrombin-stimulated human platelets.
Fälker K; Lange D; Presek P
Thromb Haemost; 2005 May; 93(5):880-8. PubMed ID: 15886804
[TBL] [Abstract][Full Text] [Related]
42. GRK2 regulates ADP signaling in platelets via P2Y1 and P2Y12.
Zhao X; Cooper M; Michael JV; Yarman Y; Baltz A; Chuprun JK; Koch WJ; McKenzie SE; Tomaiuolo M; Stalker TJ; Zhu L; Ma P
Blood Adv; 2022 Aug; 6(15):4524-4536. PubMed ID: 35793439
[TBL] [Abstract][Full Text] [Related]
43. G
Badolia R; Inamdar V; Manne BK; Dangelmaier C; Eble JA; Kunapuli SP
J Biol Chem; 2017 Sep; 292(35):14516-14531. PubMed ID: 28705934
[TBL] [Abstract][Full Text] [Related]
44. Adenosine diphosphate (ADP)-induced thromboxane A(2) generation in human platelets requires coordinated signaling through integrin alpha(IIb)beta(3) and ADP receptors.
Jin J; Quinton TM; Zhang J; Rittenhouse SE; Kunapuli SP
Blood; 2002 Jan; 99(1):193-8. PubMed ID: 11756171
[TBL] [Abstract][Full Text] [Related]
45. Functional phenotype of phosphoinositide 3-kinase p85alpha-null platelets characterized by an impaired response to GP VI stimulation.
Watanabe N; Nakajima H; Suzuki H; Oda A; Matsubara Y; Moroi M; Terauchi Y; Kadowaki T; Suzuki H; Koyasu S; Ikeda Y; Handa M
Blood; 2003 Jul; 102(2):541-8. PubMed ID: 12649157
[TBL] [Abstract][Full Text] [Related]
46. A mouse model of the protease-activated receptor 4 Pro310Leu variant has reduced platelet reactivity.
Han X; Knauss EA; Fuente M; Li W; Conlon RA; LePage DF; Jiang W; Renna SA; McKenzie SE; Nieman MT
J Thromb Haemost; 2024 Jun; 22(6):1715-1726. PubMed ID: 38508397
[TBL] [Abstract][Full Text] [Related]
47. AlphaIIbbeta3-mediated outside-in signaling induced by the agonist peptide LSARLAF utilizes ADP and thromboxane A2 receptors to cause alpha-granule secretion by platelets.
Cho MJ; Liu J; Pestina TI; Steward SA; Jackson CW; Gartner TK
J Thromb Haemost; 2003 Feb; 1(2):363-73. PubMed ID: 12871512
[TBL] [Abstract][Full Text] [Related]
48. Reduction in SOCE and Associated Aggregation in Platelets from Mice with Platelet-Specific Deletion of Orai1.
Yang L; Ottenheijm R; Worley P; Freichel M; Camacho Londoño JE
Cells; 2022 Oct; 11(20):. PubMed ID: 36291093
[TBL] [Abstract][Full Text] [Related]
49. Impaired thrombin-induced platelet activation and thrombus formation in mice lacking the Ca(2+)-dependent tyrosine kinase Pyk2.
Canobbio I; Cipolla L; Consonni A; Momi S; Guidetti G; Oliviero B; Falasca M; Okigaki M; Balduini C; Gresele P; Torti M
Blood; 2013 Jan; 121(4):648-57. PubMed ID: 23175689
[TBL] [Abstract][Full Text] [Related]
50. Effect of selective inhibition of the p38 MAP kinase pathway on platelet aggregation.
Kuliopulos A; Mohanlal R; Covic L
Thromb Haemost; 2004 Dec; 92(6):1387-93. PubMed ID: 15583748
[TBL] [Abstract][Full Text] [Related]
51. The Src family kinases and protein kinase C synergize to mediate Gq-dependent platelet activation.
Xiang B; Zhang G; Stefanini L; Bergmeier W; Gartner TK; Whiteheart SW; Li Z
J Biol Chem; 2012 Nov; 287(49):41277-87. PubMed ID: 23066026
[TBL] [Abstract][Full Text] [Related]
52. Removal of extraplatelet Na+ eliminates indomethacin-sensitive secretion from human platelets stimulated by epinephrine, ADP, and thrombin.
Connolly TM; Limbird LE
Proc Natl Acad Sci U S A; 1983 Sep; 80(17):5320-4. PubMed ID: 6577431
[TBL] [Abstract][Full Text] [Related]
53. Negative regulation of Gq-mediated pathways in platelets by G(12/13) pathways through Fyn kinase.
Kim S; Kunapuli SP
J Biol Chem; 2011 Jul; 286(27):24170-9. PubMed ID: 21592972
[TBL] [Abstract][Full Text] [Related]
54. Homologous desensitization of signalling by the alpha (alpha) isoform of the human thromboxane A2 receptor: a specific role for nitric oxide signalling.
Kelley-Hickie LP; O'Keeffe MB; Reid HM; Kinsella BT
Biochim Biophys Acta; 2007 Jun; 1773(6):970-89. PubMed ID: 17466390
[TBL] [Abstract][Full Text] [Related]
55. Differential Roles of the NADPH-Oxidase 1 and 2 in Platelet Activation and Thrombosis.
Delaney MK; Kim K; Estevez B; Xu Z; Stojanovic-Terpo A; Shen B; Ushio-Fukai M; Cho J; Du X
Arterioscler Thromb Vasc Biol; 2016 May; 36(5):846-54. PubMed ID: 26988594
[TBL] [Abstract][Full Text] [Related]
56. Endocannabinoids control platelet activation and limit aggregate formation under flow.
De Angelis V; Koekman AC; Weeterings C; Roest M; de Groot PG; Herczenik E; Maas C
PLoS One; 2014; 9(9):e108282. PubMed ID: 25264625
[TBL] [Abstract][Full Text] [Related]
57. Ask1 regulates murine platelet granule secretion, thromboxane A
Naik MU; Patel P; Derstine R; Turaga R; Chen X; Golla K; Neeves KB; Ichijo H; Naik UP
Blood; 2017 Mar; 129(9):1197-1209. PubMed ID: 28028021
[TBL] [Abstract][Full Text] [Related]
58. Assessment of neonatal platelet adhesion, activation, and aggregation.
Baker-Groberg SM; Lattimore S; Recht M; McCarty OJ; Haley KM
J Thromb Haemost; 2016 Apr; 14(4):815-27. PubMed ID: 26806373
[TBL] [Abstract][Full Text] [Related]
59. A Gi-dependent pathway is required for activation of the small GTPase Rap1B in human platelets.
Lova P; Paganini S; Sinigaglia F; Balduini C; Torti M
J Biol Chem; 2002 Apr; 277(14):12009-15. PubMed ID: 11815620
[TBL] [Abstract][Full Text] [Related]
60. Inhibition of ADP-induced platelet activation by 7-chloro-4-nitrobenz-2-oxa-1,3-diazole: covalent modification of aggregin, a putative ADP receptor.
Puri RN; Colman RW
J Cell Biochem; 1996 Apr; 61(1):97-108. PubMed ID: 8726359
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
